APA

Easterling T., Mundle S., Bracken H., Parvekar S., Mool S., Magee L. A., von Dadelszen P., Shochet T. & Winikoff B. (20191017). Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. : Lancet (London, England).

Chicago

Easterling Thomas, Mundle Shuchita, Bracken Hillary, Parvekar Seema, Mool Sulabha, Magee Laura A, von Dadelszen Peter, Shochet Tara and Winikoff Beverly. 20191017. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. : Lancet (London, England).

Harvard

Easterling T., Mundle S., Bracken H., Parvekar S., Mool S., Magee L. A., von Dadelszen P., Shochet T. and Winikoff B. (20191017). Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. : Lancet (London, England).

MLA

Easterling Thomas, Mundle Shuchita, Bracken Hillary, Parvekar Seema, Mool Sulabha, Magee Laura A, von Dadelszen Peter, Shochet Tara and Winikoff Beverly. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. : Lancet (London, England). 20191017.